Aberrantly expressed LGR4 empowers Wnt signaling in multiple myeloma by hijacking osteoblast-derived R-spondins.
about
Pathogenesis of bone disease in multiple myeloma: from bench to bedside.Wnt Signaling in Hematological Malignancies.Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential.Cancer Metastases to Bone: Concepts, Mechanisms, and Interactions with Bone Osteoblasts.RSPO3 impairs barrier function of human vascular endothelial monolayers and synergizes with pro-inflammatory IL-1
P2860
Aberrantly expressed LGR4 empowers Wnt signaling in multiple myeloma by hijacking osteoblast-derived R-spondins.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aberrantly expressed LGR4 empo ...... osteoblast-derived R-spondins.
@en
Aberrantly expressed LGR4 empo ...... osteoblast-derived R-spondins.
@nl
type
label
Aberrantly expressed LGR4 empo ...... osteoblast-derived R-spondins.
@en
Aberrantly expressed LGR4 empo ...... osteoblast-derived R-spondins.
@nl
prefLabel
Aberrantly expressed LGR4 empo ...... osteoblast-derived R-spondins.
@en
Aberrantly expressed LGR4 empo ...... osteoblast-derived R-spondins.
@nl
P2093
P2860
P356
P1476
Aberrantly expressed LGR4 empo ...... osteoblast-derived R-spondins
@en
P2093
Alexander M de Bruin
Hans Clevers
Harmen van Andel
Iris Koopmans
Marcel Spaargaren
Marie José Kersten
Sander P J Joosten
Steven T Pals
Wim de Lau
P2860
P304
P356
10.1073/PNAS.1618650114
P407
P577
2016-12-27T00:00:00Z